Microvascular Angina - Diagnosis and Treatment

  • Views:

    Views Icon 2504
  • Likes:

    Heart Icon 0


Microvascular angina is more common a condition than initially thought and poses major diagnostic and therapeutic challenges. Ischaemia triggered by coronary microvascular dysfunction affects subjects with and without coronary artery disease. The coronary microvessels are less responsive to vasodilator agents than the epicardial coronary arteries and this poses yet another difficulty in the management of patients affected by this condition.

Performed By:

Juan Carlos Kaski

Juan Carlos Kaski

Target Audience

  • Consultant cardiologists
  • Cardiologists in training
  • General physicians
  • GPs
  • SpRs

Faculty Biographies

Juan Carlos Kaski

Juan Carlos Kaski

Juan Carlos Kaski is Professor of Cardiovascular Science at St George’s, University of London (SGUL), Honorary Consultant Cardiologist at St George’s Hospital, NHS Trust, London, UK and Director of the Cardiovascular and Cell Sciences Research Institute at SGUL. Prof Kaski is Doctor of Science, University of London, immediate Past-President of ISCP (International Society of Cardiovascular Pharmacotherapy) and editorial board member and associate editor of numerous peer review journals. He is also fellow of the ESC (FESC), the ACC (FACC), the AHA (FAHA), the Royal College of Physicians (FRCP), and over 30 other scientific societies worldwide.

Prof Kaski’s research areas include mechanisms of rapid coronary artery disease progression, inflammatory and immunological mechanisms of atherosclerosis, microvascular angina and biomarkers of cardiovascular risk. Prof Kaski has published over 400 papers in peer-review journals, over 200 invited papers in cardiology journals and more than 130 book chapters. He has also edited six books on cardiovascular topics.

Professor Kaski’s main areas of research include:

  • Microvascular angina and coronary vasospasm
  • Inflammation and immunity in cardiovascular disease and acute coronary syndrome
  • Biomarkers of cardiovascular risk and rapid coronary artery disease progression
  • Pharmacotherapy in stable angina pectoris
View full profile